Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 CAD | -8.70% | -4.55% | 0.00% |
08/04 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
28/03 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacek Antas
CEO | Chief Executive Officer | - | 18/22/18 |
Director of Finance/CFO | 59 | 14/02 | |
Chief Tech/Sci/R&D Officer | - | 01/22/01 | |
Chief Tech/Sci/R&D Officer | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 18/22/18 | |
Jacek Antas
CEO | Chief Executive Officer | - | 18/22/18 |
Malgorzata Laube
BRD | Director/Board Member | - | 08/22/08 |
Janusz Grabski
BRD | Director/Board Member | - | 22/23/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 216,674,415 | 182,521,208 ( 84.24 %) | 0 | 84.24 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 38.57M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- HBP Stock
- Company Helix BioPharma Corp.